Utility of gonadotropin-releasing hormone agonists for fertility preservation in women receiving chemotherapy: pros and cons

Fertile Battle

Like Comment
Related Content

VOLUME 114, ISSUE 4, P725-738

Authors:

Marie-Madeleine Dolmans, M.D., Ph.D., Hugh S. Taylor, M.D., Kenny A. Rodriguez-Wallberg, M.D., Ph.D., Zeev Blumenfeld, M.D., Matteo Lambertini, M.D., Ph.D., Michael von Wolff, M.D., Jacques Donnez, M.D., Ph.D.

Abstract:

Con: GnRH-a should not be used for fertility preservation in women receiving chemotherapy

Pro: PRO: GnRH-a should be used for fertility preservation in women receiving chemotherapy

Read the full text here. 

Should GnRH-a be used for fertility preservation in women receiving chemotherapy?
Yes
No
Created with Survey maker

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders.